UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 243

Sortiert nach

SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells

PLoS pathogens, 2019-05, Vol.15 (5), p.e1007710-e1007710

2019

Link zum Volltext

Verfügbarkeit prüfen

Poxvirus Decapping Enzymes Enhance Virulence by Preventing the Accumulation of dsRNA and the Induction of Innate Antiviral Responses

Cell host & microbe, 2015-03, Vol.17 (3), p.320-331

2015

Link zum Volltext

Verfügbarkeit prüfen

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008845-e1008845

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge

Nature communications, 2019-02, Vol.10 (1), p.798-798, Article 798

2019

Link zum Volltext

Verfügbarkeit prüfen

The D10 Decapping Enzyme of Vaccinia Virus Contributes to Decay of Cellular and Viral mRNAs and to Virulence in Mice

Journal of Virology, 2014-01, Vol.88 (1), p.202-211

2014

Link zum Volltext

Verfügbarkeit prüfen

Highly Attenuated Smallpox Vaccine Protects Mice with and without Immune Deficiencies against Pathogenic Vaccinia Virus Challenge

Proceedings of the National Academy of Sciences - PNAS, 2004-03, Vol.101 (13), p.4590-4595

2004

Link zum Volltext

Verfügbarkeit prüfen

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins

mBio, 2017-06, Vol.8 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus

Proceedings of the National Academy of Sciences - PNAS, 2008-08, Vol.105 (31), p.10889-10894

2008

Link zum Volltext

Verfügbarkeit prüfen

Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of Dryvax

Journal of Virology, 2008-01, Vol.82 (2), p.652-663

2008

Link zum Volltext

Verfügbarkeit prüfen

Shared Modes of Protection against Poxvirus Infection by Attenuated and Conventional Smallpox Vaccine Viruses

Proceedings of the National Academy of Sciences - PNAS, 2003-08, Vol.100 (16), p.9458-9463

2003

Link zum Volltext

Verfügbarkeit prüfen

Elucidating and Minimizing the Loss by Recombinant Vaccinia Virus of Human Immunodeficiency Virus Gene Expression Resulting from Spontaneous Mutations and Positive Selection

Journal of Virology, 2009-07, Vol.83 (14), p.7176-7184

2009

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

Journal of Virology, 2003-01, Vol.77 (1), p.799-803

2003

Link zum Volltext

Verfügbarkeit prüfen

Generation of Recombinant Vaccinia Viruses

Current protocols in molecular biology (Print), 2017-01, Vol.117 (1), p.16.17.1-16.17.18

2017

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia

Journal of Virology, 2009-05, Vol.83 (9), p.4102-4111

2009

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells

Journal of virology, 2021-09, Vol.95 (19), p.e0110421-e0110421

2021

Link zum Volltext

Verfügbarkeit prüfen

Preparation of Cell Cultures and Vaccinia Virus Stocks

Current protocols in molecular biology (Print), 2017-01, Vol.117 (1), p.16.16.1-16.16.18

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles

Journal of virology, 2018-04, Vol.92 (7)

2018

Link zum Volltext

Verfügbarkeit prüfen

Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

Journal of Virology, 2002-06, Vol.76 (12), p.6138-6146

2002

Link zum Volltext

Verfügbarkeit prüfen

Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines

Journal of Virology, 2002-08, Vol.76 (15), p.7625-7631

2002

Link zum Volltext

Verfügbarkeit prüfen

Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses

Journal of virology, 2019-03, Vol.93 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog

Journal of virology, 2018-10, Vol.92 (20)

2018

Link zum Volltext

Verfügbarkeit prüfen

A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques

Journal of virology, 2018-03, Vol.92 (5)

2018

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

Journal of virology, 2017-12, Vol.91 (24)

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

The Journal of infectious diseases, 2011-03, Vol.203 (5), p.610-619

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(205)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(242)
Japanisch
(27)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(136)
Humans
(106)
Animals
(85)
Virology
(68)
Female
(60)
Biological And Medical Sciences
(50)
Male
(46)
Microbiology
(45)
Vaccinia Virus
(44)
Vaccinia Virus - Genetics
(42)
Macaca Mulatta
(36)
Immunology
(35)
Fundamental And Applied Biological Sciences. Psychology
(34)
Vaccinia Virus - Immunology
(34)
Adult
(27)
Aids Vaccines - Immunology
(27)
Mice
(26)
Medical Sciences
(24)
Vaccines, Dna - Immunology
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells

Poxvirus Decapping Enzymes Enhance Virulence by Preventing the Accumulation of dsRNA and the Induction of Innate Antiviral Responses

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge

The D10 Decapping Enzyme of Vaccinia Virus Contributes to Decay of Cellular and Viral mRNAs and to Virulence in Mice

Highly Attenuated Smallpox Vaccine Protects Mice with and without Immune Deficiencies against Pathogenic Vaccinia Virus Challenge

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus

Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of Dryvax

Shared Modes of Protection against Poxvirus Infection by Attenuated and Conventional Smallpox Vaccine Viruses

Elucidating and Minimizing the Loss by Recombinant Vaccinia Virus of Human Immunodeficiency Virus Gene Expression Resulting from Spontaneous Mutations and Positive Selection

Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

Generation of Recombinant Vaccinia Viruses

Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia

Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells

Preparation of Cell Cultures and Vaccinia Virus Stocks

Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles

Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines

Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses

RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog

A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization

Suchergebnisse filtern